Good ideas and conversation. No ads, no tracking. Login or Take a Tour!
I know. I'm sure the concept itself isn't so innovative, but here's what seems to be the beginning of a possibly useful method. Of course, there's probably still at least a couple decades of research involved before it can even be thought to go public. On page 2 of the article, it says that the treatment was experimentally given to a woman with colon cancer, but it killed her because the T-cells destroyed a certain protein target in her lungs. So...they really should make many checks to ensure that the T-cells react -only- to the desired cells. But with so many proteins and factors in a body, it's obviously not easy to always achieve that kind of result.